These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
671 related articles for article (PubMed ID: 31466948)
41. Prevalence of Helicobacter pylori infection in 160 patients with Barrett's oesophagus or Barrett's adenocarcinoma. Lord RV; Frommer DJ; Inder S; Tran D; Ward RL Aust N Z J Surg; 2000 Jan; 70(1):26-33. PubMed ID: 10696939 [TBL] [Abstract][Full Text] [Related]
42. Predictors for neoplastic progression in patients with Barrett's Esophagus: a prospective cohort study. Sikkema M; Looman CW; Steyerberg EW; Kerkhof M; Kastelein F; van Dekken H; van Vuuren AJ; Bode WA; van der Valk H; Ouwendijk RJ; Giard R; Lesterhuis W; Heinhuis R; Klinkenberg EC; Meijer GA; ter Borg F; Arends JW; Kolkman JJ; van Baarlen J; de Vries RA; Mulder AH; van Tilburg AJ; Offerhaus GJ; ten Kate FJ; Kusters JG; Kuipers EJ; Siersema PD Am J Gastroenterol; 2011 Jul; 106(7):1231-8. PubMed ID: 21577245 [TBL] [Abstract][Full Text] [Related]
43. The diagnosis and management of Barrett's esophagus. DeMeester SR; DeMeester TR Adv Surg; 1999; 33():29-68. PubMed ID: 10572561 [TBL] [Abstract][Full Text] [Related]
44. Associations of microbiota and toll-like receptor signaling pathway in esophageal adenocarcinoma. Zaidi AH; Kelly LA; Kreft RE; Barlek M; Omstead AN; Matsui D; Boyd NH; Gazarik KE; Heit MI; Nistico L; Kasi PM; Spirk TL; Byers B; Lloyd EJ; Landreneau RJ; Jobe BA BMC Cancer; 2016 Feb; 16():52. PubMed ID: 26841926 [TBL] [Abstract][Full Text] [Related]
45. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus. Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175 [TBL] [Abstract][Full Text] [Related]
46. Helicobacter pylori colonization of Barrett's esophagus and its progression to cancer. Wright TA; Myskow M; Kingsnorth AN Dis Esophagus; 1997 Jul; 10(3):196-200. PubMed ID: 9280079 [TBL] [Abstract][Full Text] [Related]
47. Long-term follow-up of Barrett's high-grade dysplasia. Weston AP; Sharma P; Topalovski M; Richards R; Cherian R; Dixon A Am J Gastroenterol; 2000 Aug; 95(8):1888-93. PubMed ID: 10950031 [TBL] [Abstract][Full Text] [Related]
48. Barrett's oesophagus patients with low-grade dysplasia can be accurately risk-stratified after histological review by an expert pathology panel. Duits LC; Phoa KN; Curvers WL; Ten Kate FJ; Meijer GA; Seldenrijk CA; Offerhaus GJ; Visser M; Meijer SL; Krishnadath KK; Tijssen JG; Mallant-Hent RC; Bergman JJ Gut; 2015 May; 64(5):700-6. PubMed ID: 25034523 [TBL] [Abstract][Full Text] [Related]
49. Genomic alterations in malignant transformation of Barrett's esophagus. Riegman PH; Vissers KJ; Alers JC; Geelen E; Hop WC; Tilanus HW; van Dekken H Cancer Res; 2001 Apr; 61(7):3164-70. PubMed ID: 11306503 [TBL] [Abstract][Full Text] [Related]
50. Controversies in Barrett's esophagus: management of high grade dysplasia. Sharma P Semin Gastrointest Dis; 2001 Jan; 12(1):26-32. PubMed ID: 11215852 [TBL] [Abstract][Full Text] [Related]
51. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754 [TBL] [Abstract][Full Text] [Related]
52. Barrett's Registry Collaboration of academic centers in Ireland reveals high progression rate of low-grade dysplasia and low risk from nondysplastic Barrett's esophagus: report of the RIBBON network. O'Byrne LM; Witherspoon J; Verhage RJJ; O'Brien M; Muldoon C; Ryan C; Buckley M; Murphy T; Reynolds R; Patchett S; Kay E; Azam H; Robb W; Arumugasamy M; Mathuna PM; Leyden J; Gargan S; Doherty G; Sheahan K; Collins C; Nath A; O'Sullivan J; Donohoe CL; Ravi N; O'Toole D; Reynolds JV Dis Esophagus; 2020 Oct; 33(10):. PubMed ID: 32193532 [TBL] [Abstract][Full Text] [Related]
53. Surveillance in patients with long-segment Barrett's oesophagus: a cost-effectiveness analysis. Kastelein F; van Olphen S; Steyerberg EW; Sikkema M; Spaander MC; Looman CW; Kuipers EJ; Siersema PD; Bruno MJ; de Bekker-Grob EW; Gut; 2015 Jun; 64(6):864-71. PubMed ID: 25037191 [TBL] [Abstract][Full Text] [Related]
54. A comparative cytopathologic and histologic study of atypia, dysplasia, and adenocarcinoma in Barrett's esophagus. Geisinger KR; Teot LA; Richter JE Cancer; 1992 Jan; 69(1):8-16. PubMed ID: 1727677 [TBL] [Abstract][Full Text] [Related]
55. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma. Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156 [TBL] [Abstract][Full Text] [Related]
56. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association. Wani S; Rubenstein JH; Vieth M; Bergman J Gastroenterology; 2016 Nov; 151(5):822-835. PubMed ID: 27702561 [TBL] [Abstract][Full Text] [Related]
57. Endoscopic therapy of esophageal premalignancy and early malignancy. Nealis TB; Washington K; Keswani RN J Natl Compr Canc Netw; 2011 Aug; 9(8):890-9. PubMed ID: 21900219 [TBL] [Abstract][Full Text] [Related]